SCHEMBL22493356

SCHEMBL22493356

C[C@H](CNC(C)(C)C)c1cccc(NC2CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 1/20 0.39
▸ CTSK P43235 1/20 0.39
▸ MALT1 Q9UDY8 2/20 0.35
▸ CYP1A2 P05177 3/20 0.33
▸ CYP2D6 P10635 3/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ LMNA P02545 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ PRMT5 O14744 1/20 0.31
▸ CCR6 P51684 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ CYP2C9 P11712 2/20 0.30
▸ IDH1 O75874 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ HTR1A P08908 1/20 0.30
▸ ADRA2A P08913 1/20 0.30
▸ CHRM1 P11229 1/20 0.30
▸ DRD1 P21728 1/20 0.30
▸ TBXA2R P21731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22481138 0.85 ADRB1 (0.56) ADRB1CTSKMALT1CYP1A2CYP2D6
SCHEMBL22481230 0.85 ADRB1 (0.56) ADRB1CTSKMALT1CYP1A2CYP2D6
SCHEMBL26858873 0.84 ADRB1 (0.38) ADRB1CTSKMALT1CYP1A2CYP2D6
SCHEMBL22481122 0.81 ADRB1 (0.54) ADRB1CTSKCYP1A2CYP2D6CYP3A4
SCHEMBL22481296 0.81 ADRB1 (0.54) ADRB1CTSKCYP1A2CYP2D6CYP3A4
SCHEMBL22481314 0.81 ADRB1 (0.54) ADRB1CTSKCYP1A2CYP2D6CYP3A4
SCHEMBL22481295 0.81 ADRB1 (0.54) ADRB1CTSKCYP1A2CYP2D6CYP3A4
SCHEMBL22493237 0.80 CTSK (0.41) ADRB1CTSKCYP1A2CYP2D6LMNA
SCHEMBL22481308 0.75 ADRB1 (0.54) ADRB1CYP2D6CYP3A4LMNAHIF1A
SCHEMBL22864246 0.74 ADRB1 (0.44) ADRB1CYP2D6LMNAHIF1AIDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 — — WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 — — WO disclosed
Send feedback